Detalhe da pesquisa
1.
Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.
Br J Haematol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38811201
2.
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
Blood
; 139(17): 2642-2652, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226723
3.
Deep Vein Thrombosis After a Wild Bee Sting.
J Pediatr Hematol Oncol
; 44(1): e241-e242, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512868
4.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
JAMA
; 325(15): 1513-1523, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877274
5.
Silent cerebral infarct in sickle cell anemia patients of southern Turkey
Turk J Med Sci
; 50(8): 1887-1893, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599969
6.
Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
Pediatr Blood Cancer
; 66(10): e27923, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321910
7.
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload.
Blood
; 125(25): 3868-77, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934475
8.
A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in ß-thalassemia major (CORDELIA).
Blood
; 123(10): 1447-54, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385534
9.
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.
Eur J Haematol
; 95(3): 244-53, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25418187
10.
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.
Am J Hematol
; 90(2): 91-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25345697
11.
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.
Acta Haematol
; 134(4): 233-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26138856
12.
Membranous nephropathy presenting with nephrotic syndrome in a child with thalassemia major.
Pediatr Int
; 57(4): 711-3, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25711242
13.
Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis.
Pediatr Blood Cancer
; 61(5): 879-84, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24376176
14.
A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients.
Turk J Haematol
; 31(1): 17-24, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24764725
15.
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.
Blood
; 118(4): 884-93, 2011 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628399
16.
Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.
Pediatr Endocrinol Rev
; 11(2): 167-80, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24575552
17.
Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years.
Blood Adv
; 7(4): 611-619, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018224
18.
Rare coagulation disorders: a retrospective analysis of 156 patients in Turkey.
Turk J Haematol
; 29(1): 48-54, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24744623
19.
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study.
Blood Adv
; 6(4): 1243-1254, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847228
20.
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Haematol
; 8(5): e334-e343, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894169